Research Article

Teledentistry as a Supportive Tool for Dentists in Diagnosing MRONJ in Northern Cyprus

Table 3

Knowledge of different AR and AA drugs by participants and comparison of administration of bisphosphonates with years of experience. Italic shows statistical significance ().

MedicationDentists (%)Specialists (%) valueYears of experience

Alendronate (Fosamax ©)56.6%71%Administration1-1010-20>20 value
Zoledronic acid (Zometa ©)50.9%53.3%Intravenously86.5%44.4%54.5%
Risedronate (Actonel ©)5.7%25.0%Intramuscularly10.1%018.2%
Ibandronate (Bonviva ©)17%38.3%Oral91%100%100%
Denosumab (Prolia ©)1716.7%Subcutaneously1.1%11.1%0